News
News

The latest updates from AFAR.

Board Member in the News: Scientific Director Steven Austad's latest Next Avenue column on what's ahead in aging research, featuring 13 AFAR experts

Jan 31
2019

Board Member in the News: Scientific Director Steven Austad's latest Next Avenue column on what's ahead in aging research, featuring 13 AFAR experts

On January 30, 2019, Next Avenue published the latest column by AFAR Scientific Director Steven Austad, PhD. “Last Year’s Research on Aging Hints at What Lies Ahead” reflects on insights gained in the field last year and spotlights studies recently published by a range of AFAR experts including: Research by led by 1998 AFAR Research Grant for Junior Faculty recipient and 2013 Vincent Cristofalo Rising Star Award in Aging Research recipient Valter Longo, PhD as well as 2014 Julie Martin Mid-Career Award in Aging Research recipient Satchidananda Panda, Ph.D. on dietary timing and periodic fasting to extend healthspan, Research by 2017…


View MoreREAD MORE


Experts in the News: Campisi, Guarente, Longo, and Vijg on interventions to extend healthspan in Medium

Jan 29
2019

Experts in the News: Campisi, Guarente, Longo, and Vijg on interventions to extend healthspan in Medium

  On January 26, 2019, Medium featured AFAR experts Judy Campisi, PhD, Leonard Guarente, PhD, Valter Longo, MD, and Jan Vijg, PhD in an article exploring limits to human lifespan and the promise of extending healthspan through biomedical research and interventions. Dr. Campisi is a 1990 AFAR Research Grant for Junior Faculty recipient. Dr. Guarente is a 2015 Irving S. Wright Award of Distinction recipient. Dr. Longo is a 1998 AFAR Research Grant for Junior Faculty recipient and 2013 Vincent Cristofalo Rising Star Award in Aging Research recipient. Dr. Vijg is a 2012 Irving S. Wright Award of Distinction recipient. Read “How long will we…


View MoreREAD MORE


Grantees in the News: David Holtzman and Brendan Lucey’s research on lack of sleep and Alzheimer’s proteins in Science

Jan 29
2019

Grantees in the News: David Holtzman and Brendan Lucey’s research on lack of sleep and Alzheimer’s proteins in Science

  On January 24, 2019, Science published research co-authored by AFAR experts David M. Holtzman, MD and Brendan P. Lucey, MD exploring how lack of sleep is tied to an increase in two Alzheimer’s proteins. Dr. Holtzman is a 1995 Beeson Scholar. Dr. Lucey is a 2016 Beeson Scholar. Read “The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans” in Science here, as well as a related story in Science News here.  


View MoreREAD MORE


Grantee in the News: Valter Longo featured in Medium’s Health Lifestyle Diary

Jan 16
2019

Grantee in the News: Valter Longo featured in Medium’s Health Lifestyle Diary

On January 15, 2019, Medium featured AFAR expert Valter Longo, PhD and his insights on healthspan, intermittent fasting, biomarkers, and more. Dr. Longo is a 2013 Vincent Cristofalo Rising Star Award in Aging Research recipient and a 1998 AFAR Research Grant for Junior Faculty awardee. Read the article in Medium’s Health Lifestyle Diary here.  


View MoreREAD MORE


Experts in the News: Boustani and Reuben on Medicare payment for team-based care for dementia in Health Affairs

Jan 16
2019

Experts in the News: Boustani and Reuben on Medicare payment for team-based care for dementia in Health Affairs

  The January 2019 issue of Health Affairs journal features an article co-authored by AFAR experts Malaz Boustani, MD, MPH, and David Reuben, MD on collaborative care models for dementia and Medicare payment. Dr. Boustani is a 2005 Beeson scholar and a former Centers of Excellence fellow. Dr. Reuben is a former Centers of Excellence fellow. Read “An Alternative Payment Model To Support Widespread Use Of Collaborative Dementia Care Models” here and a related press release from the Reginstrief Institute here.  


View MoreREAD MORE


Board Member in the News: Jay Olshansky discusses the longevity dividend and drug interventions with PBS Next Avenue

Jan 11
2019

Board Member in the News: Jay Olshansky discusses the longevity dividend and drug interventions with PBS Next Avenue

On January 9, 2019, PBS Next Avenue featured an interview with AFAR expert S. Jay Olshansky, PhD on the longevity dividend and drug interventions to slow aging. Dr. Olshansky is a member of AFAR’s Board of Directors. Read “Will We Soon Be Taking a Pill to Slow Aging?” here.


View MoreREAD MORE


AFAR Experts in the News: Kirkland, LeBrasseur, and Musi’s research in EBioMedicine on promising findings from first human trial of senolytic drugs.

Jan 09
2019

AFAR Experts in the News: Kirkland, LeBrasseur, and Musi’s research in EBioMedicine on promising findings from first human trial of senolytic drugs.

On January 5, 2019, EBioMedicine (a publication of The Lancet) published research co-authored by AFAR experts James L. Kirkland, MD, PhD, Nathan LeBrasseur, PhD, and Nicholas Musi, MD sharing promising findings from the first human trials of senolytic drugs. Dr. Kirkland is AFAR’s Board President-Elect and a 2012 Glenn/AFAR Breakthroughs in Gerontology Award recipient. Dr. LeBrasseur is a 2002 Glenn/AFAR Scholarships for Research in the Biology of Aging recipient. Dr. Musi is 2007 Beeson Scholar and has served on AFAR’s National Scientific Advisory Council. Additionally, Dr. Musi is co-leader of the Healthspan and Functional Assessment Core at…


View MoreREAD MORE


Board member in the News: Nir Barzilai on longevity genes in Forbes

Jan 09
2019

Board member in the News: Nir Barzilai on longevity genes in Forbes

On January 6, 2019, Forbes featured an interview with AFAR expert Nir Barziliai, MD on the role of genes in human longevity. Dr. Barzilai is AFAR’s Deputy Scientific Director, a multiple grantee, and the recipient of our 2010 Irving S. Wright Award. Read “A Deeper Look At Human Longevity Genes” on Forbes.com, in partnership with the Milken Institute Center for the Future of Aging and PBS Next Avenue, here.  


View MoreREAD MORE


Board Member in the News: James Kirkland's research in Cell Metabolism on obesity-induced Senescence and anxiety in mice.

Jan 07
2019

Board Member in the News: James Kirkland's research in Cell Metabolism on obesity-induced Senescence and anxiety in mice.

On January 3, Cell Metabolism published research co-authored by AFAR expert James L. Kirkland, MD, PhD exploring how in mouse studies, obesity increases the level of the brain’s senescent cells, which, in turn, are linked to anxiety. Dr. Kirkland is AFAR’s President-Elect and a 2012 Glenn/AFAR Breakthroughs in Gerontology Award recipient. Read the research article—"Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis”—here and a related press release here.  


View MoreREAD MORE


Grantees in the News: Catherine Kaczorowski and Sarah Neuner’s research in Neuron on a better mouse model for more precise Alz research

Jan 07
2019

Grantees in the News: Catherine Kaczorowski and Sarah Neuner’s research in Neuron on a better mouse model for more precise Alz research

  On December 27, 2019, Neuron published research co-authored by AFAR experts Catherine Kaczorowski, PhD and Sarah Neuner exploring how incorporating genetic diversity into a mouse model of Alzheimer’s disease resulted in greater overlap with the genetic, molecular, and clinical features of the disease. Dr. Kaczorwoski is a 2014 New Investigator Award in Alzheimer's Disease recipient and a member of the Glenn Foundation for Medical Research Postdoctoral Fellowship Program in Aging Research Selection Committee for 2017 and 2018. Ms. Neuner is a 2015 Glenn/AFAR Scholarships for Research in the Biology of Aging recipient and PhD candidate at the Jackson Laborotory, one of…


View MoreREAD MORE




BACK TO TOPBACK TO TOP